Target
Beta-lactamase
Ligand
BDBM467000
Substrate
n/a
Meas. Tech.
Inhibition of Beta-Lactamase Enzymes
IC50
18.0±n/a nM
Citation
 Comita-Prevoir, JDurand-Reville, TFGauthier, LO''Donnell, JRomero, JTommasi, RVerheijen, JCWu, FWu, XZhang, J Beta-lactamase inhibitor compounds US Patent  US10800778 Publication Date 10/13/2020 
Target
Name:
Beta-lactamase
Synonyms:
Beta-lactamase | OXA-48 | Synonyms=blaOXA-48 | bla
Type:
PROTEIN
Mol. Mass.:
30363.94
Organism:
Klebsiella pneumoniae
Description:
ChEMBL_103606
Residue:
265
Sequence:
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAITKEVLKQEKIIP
  
Inhibitor
Name:
BDBM467000
Synonyms:
2-(((2S,5R)-2-carbamoyl-4-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl)oxy)-2,2-difluoroacetic acid lithium salt | US10800778, Example 91
Type:
Small organic molecule
Emp. Form.:
C10H11F2N3O5
Mol. Mass.:
291.2082
SMILES:
CC1=C[C@H](N2C[C@@H]1N(OC(F)(F)C(O)=O)C2=O)C(N)=O |r,t:1|
Structure:
Search PDB for entries with ligand similarity: